The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.
Biomarkers of sepsis
Abstract
BACKGROUND: A complex network of biological mediators underlies the clinical syndrome of sepsis. The nonspecific physiologic criteria of sepsis syndrome or the systemic inflammatory response syndrome do not adequately identify patients who might benefit from either conventional anti-infective therapies or from novel therapies that target specific mediators of sepsis. Validated biomarkers of sepsis may improve diagnosis and therapeutic decision making for these high-risk patients. OBJECTIVES: To develop a methodologic framework for the identification and validation of biomarkers of sepsis. METHODS: A small group meeting of experts in clinical epidemiology, biomarker development, and sepsis clinical trials; selective narrative review of the biomarker literature. RESULTS: The utility of a biomarker is a function of the degree to which it adds value to the available clinical information in the domains of screening, diagnosis, risk stratification, and monitoring of the response to therapy. We identified needs for greater standardization of biomarker methodologies, greater methodologic rigor in biomarker studies, wider integration of biomarkers into clinical studies (in particular, early phase studies), and increased collaboration among investigators, pharmaceutical industry, biomarker industry, and regulatory agencies. CONCLUSIONS: Biomarkers promise to transform sepsis from a physiologic syndrome to a group of distinct biochemical disorders. This transformation could aid therapeutic decision making, and hence improve the prognosis for patients with sepsis, but will require an unprecedented degree of systematic investigation and collaboration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bone, R. C., Balk, R. A., Cerra, F. B., Dellinger, R. P., Fein, A. M., Knaus, W. A., Schein, R. M. H., & Sibbald, W. J. (1992) · Chest · doi:10.1378/chest.101.6.1644 · Cited by 13,198
(2000) · New England Journal of Medicine · doi:10.1056/nejm200005043421801 · Cited by 12,941
Angus, D. C., Linde-Zwirble, W. T., Lidicker, J., Clermont, G., Carcillo, J., & Pinsky, M. R. (2001) · Critical Care Medicine · doi:10.1097/00003246-200107000-00002 · Cited by 8,503
Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework
(2001) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2001.113989 · Cited by 6,762
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference
Levy, M. M., Fink, M. P., Marshall, J. C., Abraham, E., Angus, D., Cook, D., Cohen, J., Opal, S. M., Vincent, J.-L., & Ramsay, G. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000050454.01978.3b · Cited by 5,995
Self-citationThe epidemiology of sepsis in the United States from 1979 through 2000
Martin, G. S., Mannino, D. M., Eaton, S., & Moss, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022139 · Cited by 5,841
A Multicenter, Randomized, Controlled Clinical Trial of Transfusion Requirements in Critical Care
Hébert, P. C., Wells, G., Blajchman, M. A., Marshall, J., Martin, C., Pagliarello, G., Tweeddale, M., Schweitzer, I., & Yetisir, E. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902113400601 · Cited by 5,187
Self-citationTowards complete and accurate reporting of studies of diagnostic accuracy: The STARD Initiative.
Bossuyt, P. M., Reitsma, J. B., Bruns, D. E., Gatsonis, C. A., Glasziou, P. P., Irwig, L. M., Lijmer, J. G., Moher, D., Rennie, D., de Vet, H. C. W., et al. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-1-200301070-00010 · Cited by 3,219
Annane, D. (2002) · JAMA · doi:10.1001/jama.288.7.862 · Cited by 3,087
Sepsis in European intensive care units: Results of the SOAP study*
Vincent, J.-L., Sakr, Y., Sprung, C. L., Ranieri, V. M., Reinhart, K., Gerlach, H., Moreno, R., Carlet, J., Le Gall, J.-R., & Payen, D. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000194725.48928.3a · Cited by 2,836
Self-citationHigh serum procalcitonin concentrations in patients with sepsis and infection
Assicot, M., Bohuon, C., Gendrel, D., Raymond, J., Carsin, H., & Guilbaud, J. (1993) · The Lancet · doi:10.1016/0140-6736(93)90277-n · Cited by 2,197
Ribic, C. M., Sargent, D. J., Moore, M. J., Thibodeau, S. N., French, A. J., Goldberg, R. M., Hamilton, S. R., Laurent-Puig, P., Gryfe, R., Shepherd, L. E., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022289 · Cited by 2,160
Hydrocortisone Therapy for Patients with Septic Shock
Sprung, C. L., Annane, D., Keh, D., Moreno, R., Singer, M., Freivogel, K., Weiss, Y. G., Benbenishty, J., Kalenka, A., Forst, H., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa071366 · Cited by 2,132
Self-citationSurrogate endpoints in clinical trials: Definition and operational criteria
Prentice, R. L. (1989) · Statistics in Medicine · doi:10.1002/sim.4780080407 · Cited by 2,057
A Multicenter, Randomized, Controlled Clinical Trial of Transfusion Requirements in Critical Care
(1999) · New England Journal of Medicine · doi:10.1056/nejm199904013401322 · Cited by 2,037
An Epidemic, Toxin Gene–Variant Strain of Clostridium difficile
McDonald, L. C., Killgore, G. E., Thompson, A., Owens, R. C., Kazakova, S. V., Sambol, S. P., Johnson, S., & Gerding, D. N. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051590 · Cited by 2,006
Empirical evidence of design-related bias in studies of diagnostic tests.
Lijmer, J. G. (1999) · JAMA · doi:10.1001/jama.282.11.1061 · Cited by 1,861
Simon, L., Gauvin, F., Amre, D. K., Saint-Louis, P., & Lacroix, J. (2004) · Clinical Infectious Diseases · doi:10.1086/421997 · Cited by 1,787
A network-based analysis of systemic inflammation in humans
Program, I. A. H. R. T. I. L. S. C. R., Calvano, S. E., Xiao, W., Richards, D. R., Felciano, R. M., Baker, H. V., Cho, R. J., Chen, R. O., Brownstein, B. H., Cobb, J. P., et al. (2005) · Nature · doi:10.1038/nature03985 · Cited by 1,429
Multiple Biomarkers for the Prediction of First Major Cardiovascular Events and Death
Wang, T. J., Gona, P., Larson, M. G., Tofler, G. H., Levy, D., Newton-Cheh, C., Jacques, P. F., Rifai, N., Selhub, J., Robins, S. J., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055373 · Cited by 1,343
Monocyte deactivation in septic patients: Restoration by IFN-γ treatment
Döcke, W.-D., Randow, F., Syrbe, U., Krausch, D., Asadullah, K., Reinke, P., Volk, H.-D., & Kox, W. (1997) · Nature Medicine · doi:10.1038/nm0697-678 · Cited by 1,190
Christ-Crain, M., Jaccard-Stolz, D., Bingisser, R., Gencay, M. M., Huber, P. R., Tamm, M., & Müller, B. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15591-8 · Cited by 1,096
Increased mortality associated with growth hormone treatment in critically ill adults
Takala, J., Ruokonen, E., Webster, N. R., Nielsen, M. S., Zandstra, D. F., Vundelinckx, G., & Hinds, C. J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909093411102 · Cited by 1,023
López, A., Lorente, J. A., Steingrub, J., Bakker, J., McLuckie, A., Willatts, S., Brockway, M., Anzueto, A., Holzapfel, L., Breen, D., et al. (2004) · Critical Care Medicine · doi:10.1097/01.ccm.0000105581.01815.c6 · Cited by 921
INCREASED MORTALITY ASSOCIATED WITH GROWTH HORMONE TREATMENT IN CRITICALLY ILL ADULTS
Akala, J. U. T., Uokonen, E. S. R., Igel, N., Ebster, R. W., Ielsen, M. I. S. N., Andstra, D. U. F. Z., Undelinckx, G. U. V., & Inds, H. J. H. (1999) · Cited by 889
Procalcitonin Guidance of Antibiotic Therapy in Community-acquired Pneumonia: A Randomized Trial
Christ-Crain, M., Stolz, D., Bingisser, R., Müller, C., Miedinger, D., Huber, P. R., Zimmerli, W., Harbarth, S., Tamm, M., & Müller, B. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200512-1922oc · Cited by 884
Genetic and Environmental Influences on Premature Death in Adult Adoptees
Sørensen, T. I. A., Nielsen, G. G., Andersen, P. K., & Teasdale, T. W. (1988) · New England Journal of Medicine · doi:10.1056/nejm198803243181202 · Cited by 827
Uzzan, B., Cohen, R., Nicolas, P., Cucherat, M., & Perret, G.-Y. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000226413.54364.36 · Cited by 738
Sepsis syndrome: a valid clinical entity. Methylprednisolone Severe Sepsis Study Group.
Bone, R. C., Fisher, C. J., Clemmer, T. P., Gj, S., METZ, C. A., & BALK, R. A. (1989) · PubMed · Cited by 689
Epidemiology of Sepsis Syndrome in 8 Academic Medical Centers
Sands, K. E. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03550030074038 · Cited by 663
Lopinavir–Ritonavir versus Nelfinavir for the Initial Treatment of HIV Infection
Walmsley, S., Bernstein, B., King, M., Arribas, J., Beall, G., Ruane, P., Johnson, M., Johnson, D., Lalonde, R., Japour, A., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012354 · Cited by 647
Soluble Triggering Receptor Expressed on Myeloid Cells and the Diagnosis of Pneumonia
Gibot, S., Cravoisy, A., Levy, B., Bene, M.-C., Faure, G., & Bollaert, P.-E. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031544 · Cited by 645
Abraham, E. (1998) · The Lancet · doi:10.1016/s0140-6736(00)80009-4 · Cited by 624
Abraham, E. H., Anzueto, A., Gutiérrez, G., Tessler, S., Pedro, G. S. S., Wunderink, R. G., Nogare, A. R. D., Nasraway, S. A., Berman, S., Cooney, R. N., et al. (1998) · PubMed · Cited by 622
Opal, S. M., Scannon, P. J., Vincent, J., White, M., Carroll, S. F., Palardy, J. E., Parejo, N. A., Pribble, J. P., & Lemke, J. H. (1999) · The Journal of Infectious Diseases · doi:10.1086/315093 · Cited by 609
Multiplex bead array assays: Performance evaluation and comparison of sensitivity to ELISA☆
ELSHAL, M., & MCCOY, J. (2006) · Methods · doi:10.1016/j.ymeth.2005.11.010 · Cited by 568
Sepsis syndrome: A valid clinical entity
BONE, R. C., FISHER, C. J., CLEMMER, T. P., SLOTMAN, G. J., METZ, C. A., & BALK, R. A. (1989) · Critical Care Medicine · doi:10.1097/00003246-198905000-00002 · Cited by 537
Clinical Trial Designs for Predictive Marker Validation in Cancer Treatment Trials
Sargent, D. J., Conley, B. A., Allegra, C., & Collette, L. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.112 · Cited by 499
The Limitations of Risk Factors as Prognostic Tools
Ware, J. H. (2006) · New England Journal of Medicine · doi:10.1056/nejmp068249 · Cited by 466
The ‘cytokine profile’: a code for sepsis
Ulloa, L., & Tracey, K. J. (2005) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.12.007 · Cited by 440
Dhainaut, J. ‐., Yan, S. B., Joyce, D. E., Pettilä, V., Basson, B., Brandt, J. T., Sundin, D. P., & Levi, M. (2004) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2004.00955.x · Cited by 426
New developments in the diagnosis of bloodstream infections
Peters, R. P., van Agtmael, M. A., Danner, S. A., Savelkoul, P. H., & Vandenbroucke-Grauls, C. M. (2004) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(04)01205-8 · Cited by 398
Panacek, E. A., Marshall, J. C., Albertson, T. E., Johnson, D. H., Johnson, S., MacArthur, R. D., Miller, M., Barchuk, W. T., Fischkoff, S., Kaul, M., et al. (2004) · Critical Care Medicine · doi:10.1097/01.ccm.0000145229.59014.6c · Cited by 387
Self-citationMarshall, J. C., Foster, D., Vincent, J., Cook, D. J., Cohen, J., Dellinger, R. P., Opal, S., Abraham, E., Brett, S. J., Smith, T., et al. (2004) · The Journal of Infectious Diseases · doi:10.1086/422254 · Cited by 365
Self-citationMeta-analysis for the evaluation of potential surrogate markers
Daniels, M. J., & Hughes, M. D. (1997) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19970915)16:17<1965::aid-sim630>3.0.co;2-m · Cited by 362
C-reactive protein as a marker of infection in critically ill patients
Póvoa, P., Coelho, L., Almeida, E., Fernandes, A., Mealha, R., Moreira, P., & Sabino, H. (2005) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2004.01044.x · Cited by 346
Such stuff as dreams are made on: mediator-directed therapy in sepsis
Marshall, J. C. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1084 · Cited by 264
Self-citationSingle nucleotide polymorphism genotyping: biochemistry, protocol, cost and throughput
Chen, X., & Sullivan, P. F. (2003) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500167 · Cited by 249
Surrogate endpoints in clinical trials: Cardiovascular diseases
Wittes, J., Lakatos, E., & Probstfield, J. (1989) · Statistics in Medicine · doi:10.1002/sim.4780080405 · Cited by 247
Marshall, J. C., Vincent, J.-L., Fink, M. P., Cook, D. J., Rubenfeld, G., Foster, D., Fisher, C. J., Faist, E., & Reinhart, K. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000065186.67848.3a · Cited by 241
Self-citationGenetic Polymorphisms in Sepsis and Septic Shock
Holmes, C. L., Russell, J. A., & Walley, K. R. (2003) · Chest · doi:10.1378/chest.124.3.1103 · Cited by 219
Liu, T., Qian, W.-J., Mottaz, H. M., Gritsenko, M. A., Norbeck, A. D., Moore, R. J., Purvine, S. O., Camp, D. G., & Smith, R. D. (2006) · Molecular & Cellular Proteomics · doi:10.1074/mcp.t600039-mcp200 · Cited by 208
Cancer BiomarkersAn Invitation to the Table
Dalton, W. S., & Friend, S. H. (2006) · Science · doi:10.1126/science.1125948 · Cited by 202
Solomkin, J. S., Reinhart, H. H., Dellinger, E. P., Bohnen, J. M., Rotstein, O. D., Vogel, S. B., Simms, H. H., Hill, C. S., Bjornson, H. S., Haverstock, D. C., et al. (1996) · Annals of Surgery · doi:10.1097/00000658-199603000-00012 · Cited by 192
Statistical evaluation of biomarkers as surrogate endpoints: a literature review
Weir, C. J., & Walley, R. J. (2006) · Statistics in Medicine · doi:10.1002/sim.2319 · Cited by 175
Predictive Markers in Breast and Other Cancers: A Review
Duffy, M. J. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2004.046227 · Cited by 174
New strategies for clinical trials in patients with sepsis and septic shock
Cohen, J., Guyatt, G., Bernard, G. R., Calandra, T., Cook, D., Elbourne, D., Marshall, J., Nunn, A., & Opal, S. (2001) · Critical Care Medicine · doi:10.1097/00003246-200104000-00039 · Cited by 158
Self-citationTNF and TNFR biology in health and disease.
McDermott, M. (2001) · PubMed · Cited by 152
Marshall, J. C., Vincent, J., Guyatt, G. H., Angus, D. C., Abraham, E. H., Bernard, G. R., Bombardier, C., Calandra, T., Jørgensen, H. S., Sylvester, R. J., et al. (2005) · Critical Care Medicine · doi:10.1097/01.ccm.0000174478.70338.03 · Cited by 146
Self-citationTomic, V., Rußwurm, S., Möller, E., Claus, R. A., Blaess, M. F., Brunkhorst, F. M., Bruegel, M., Bode, K., Bloos, F., Wippermann, J., et al. (2005) · Circulation · doi:10.1161/circulationaha.104.531152 · Cited by 135
Self-citationHighly parallel microbial diagnostics using oligonucleotide microarrays
Loy, A., & Bodrossy, L. (2005) · Clinica Chimica Acta · doi:10.1016/j.cccn.2005.05.041 · Cited by 132
Lassere, M. N., Johnson, K. R., Boers, M., Tugwell, P., Brooks, P., Simon, L. S., Strand, V., Conaghan, P. G., Østergaard, M., Maksymowych, W. P., et al. (2007) · PubMed · Cited by 125
Comparison of three multiplex cytokine analysis systems: Luminex, SearchLight™ and FAST Quant®
Lash, G. E., Scaife, P. J., Innes, B. A., Otun, H. A., Robson, S., Searle, R. F., & Bulmer, J. N. (2006) · Journal of Immunological Methods · doi:10.1016/j.jim.2005.12.007 · Cited by 75
Optimization of detection of bacterial endotoxin in plasma with the Limulus test.
Roth, R. I., Levin, F. C., & Levin, J. (1990) · PubMed · Cited by 66
Fisher, J. A., Fikry, C., & Troxel, A. B. (2006) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-05-0198 · Cited by 54
Association of TNF-α polymorphisms in Crohn disease
Zipperlen, K., Peddle, L., Melay, B., Hefferton, D., & Rahman, P. (2004) · Human Immunology · doi:10.1016/j.humimm.2004.10.004 · Cited by 35
Intensive care triage—The hardest rationing decision of them all*
Levin, P. D., & Sprung, C. L. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000208355.77757.9c · Cited by 31
Rethinking Sepsis: From Concepts to Syndromes to Diseases
Marshall, J. C. (1999) · Sepsis · doi:10.1023/a:1009830809222 · Cited by 23
Self-citationSummarizing Studies of Diagnostic Test Performance
Montori, V. M., & Guyatt, G. H. (2003) · Clinical Chemistry · doi:10.1373/clinchem.2003.024935 · Cited by 12
Cited by
Pierrakos, C., & Vincent, J.-L. (2010) · Critical Care · doi:10.1186/cc8872 · Cited by 1,377
Why have clinical trials in sepsis failed?
Marshall, J. C. (2014) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2014.01.007 · Cited by 805
Self-citationBiomarkers of sepsis: time for a reappraisal
Pierrakos, C., Velissaris, D., Bisdorff, M., Marshall, J. C., & Vincent, J.-L. (2020) · Critical Care · doi:10.1186/s13054-020-02993-5 · Cited by 713
Self-citationStearns-Kurosawa, D. J., Osuchowski, M. F., Valentine, C., Kurosawa, S., & Remick, D. G. (2011) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130327 · Cited by 549
New Approaches to Sepsis: Molecular Diagnostics and Biomarkers
Reinhart, K., Bauer, M., Riedemann, N. C., & Hartog, C. S. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.00016-12 · Cited by 533
Self-citation
Metadata
- Authors
- Marshall, J. C., & Reinhart, K.
- Venue
- Critical Care Medicine
- Published
- 2009-07
- Volume
- 37
- Issue
- 7
- Pages
- 2290-2298
- ISSN
- 0090-3493 (ISSN-L)
- OpenAlex
- W2005896876
- Cited by
- 294
- References
- 69
- FWCI
- 17.68
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.